G6PC1 and type 2 diabetes mellitus: We postulated that obesogenic factors might upregulate hepatic METTL14 and METTL3 to activate the G6pc mRNA m6A/G6pc synthesis/HGP pathway, thereby exacerbating type 2 diabetes progression.